CureMatch, Inc. logo

CureMatch, Inc.

AI-based Precision Medicine Decision Support for Oncology

26 employees · est. 2015 · San Diego, United States

VS
Predicine logo

Predicine

Advancing precision medicine through next-generation liquid biopsy oncology platform

89 employees · est. 2015 · Hayward, United States

Predicine is the larger of the two.

Side-by-Side Comparison

CureMatch, Inc. Predicine
Founded
2015 2015
Headquarters
San Diego, United States Hayward, United States
Employees
26 89 larger
Industry
Analytics, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Series Unknown Not tracked yet
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
3 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Precision Medicine, Oncology, AI-based Decision Support, Cancer Treatment, Personalized Medicine, Digital Health, Combination Therapy, Molecular Tumor Profiling, Oncologists, Therapeutic Options, Research, Clinical Decision Support, San Diego, Artificial Intelligence (AI) Precision Medicine, Liquid Biopsy, Oncology Diagnostics, Biomarker Development, Genomic Profiling, Clinical Trials Support, Molecular Diagnostics, Therapy Monitoring, Minimal Residual Disease Detection, Early Cancer Detection, Genomic Data Analytics, Biopharma Partnerships, Infectious Disease Diagnostics, MRD (Minimal Residual Disease) Monitoring, COVID-19 Diagnostics
Website
curematch.com predicine.com
CureMatch, Inc. logo

About CureMatch, Inc.

CureMatch, Inc. is a promising AI-based Precision Medicine startup focused on providing digital decision support solutions for oncology. Established in 2015 and headquartered in the United States, the company's slogan "AI-based Precision Medicine Decision Support for Oncology" succinctly encapsulate...

Predicine logo

About Predicine

Predicine is a global molecular insights company that focuses on advancing precision medicine in oncology. The company has developed a breakthrough cell-free DNA- and cell-free RNA-based liquid biopsy technology, enabling minimally invasive molecular diagnosis for treatment selection, therapy monito...

We will tell you when either one moves

BounceWatch watches CureMatch, Inc. and Predicine for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CureMatch, Inc. and Predicine — by email.

Frequently Asked Questions

CureMatch, Inc. — AI-based Precision Medicine Decision Support for Oncology. Predicine — Advancing precision medicine through next-generation liquid biopsy oncology platform. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CureMatch, Inc. and Predicine operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CureMatch, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at CureMatch, Inc. on 12 Sep 2024, and Predicine on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy